Risk of Severe COVID-19 Increased by Metabolic Dysfunction-associated Fatty Liver Disease: A Meta-analysis.,Journal of Clinical Gastroenterology

当前位置： X-MOL 学术 › J. Clinical Gastroenterol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Risk of Severe COVID-19 Increased by Metabolic Dysfunction-associated Fatty Liver Disease: A Meta-analysis.
Journal of Clinical Gastroenterology ( IF 2.9 ) Pub Date : 2021-08-18 , DOI: 10.1097/mcg.0000000000001605
Ziwen Tao ₁ , Yueyue Li , Baoquan Cheng , Tao Zhou , Yanjing Gao

Affiliation

The prevalence of metabolic dysfunction-associated fatty liver disease (MAFLD) in coronavirus disease-2019 (COVID-19) patients and whether it affects the outcomes of COVID-19 requires investigation.

中文翻译：